Motixafortide

Tax included
Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ~1 nM.
HY-P0171

Data sheet

Size
Multiple sizes
Reactivity
CXCR
Application
Cancer-programmed cell death
CAS
664334-36-5